Wegovy weight loss results: what TikTok shows vs. trial data

What did @zseborah actually say?

Straightforwardly: nothing medically relevant. The transcript is entirely song lyrics, seemingly auto-generated captions from a background track playing during the video. Lines like "Baby, what the hell is my heart?" and "This man is testing me" are not weight loss claims. They are not even coherent sentences about GLP-1 medications. Whatever @zseborah intended to communicate about Wegovy, it did not make it into the transcript we have to work with.

The caption reads "And that's not even the end," which implies continuation of a longer story, possibly about a Wegovy journey. But without audible, transcribed speech from the creator, there is no factual content here to evaluate.

Does the science back this up?

There is no claim here to test against the science. The transcript is song lyrics, not medical commentary. That said, the video exists in the context of the #wegovyweightloss hashtag, which carries its own ecosystem of claims worth addressing separately, even if this specific video does not make them explicitly.

Wegovy (semaglutide 2.4 mg weekly) does have a substantial evidence base. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed participants lost an average of 14.9% of body weight over 68 weeks. The SELECT trial (Lincoff et al., 2023, NEJM) showed a 20% reduction in major cardiovascular events in people with obesity and established cardiovascular disease. These are real, peer-reviewed findings, not marketing.

What did they get wrong (or right)?

This is genuinely not possible to assess. There are no claims to evaluate as right or wrong. The auto-captioning technology, likely TikTok's own speech recognition, has clearly captured background music rather than the creator's voice. This is a technical failure of the captioning system, not a credibility failure on the creator's part.

What is worth noting is that 78,700 people watched this video under a GLP-1 hashtag. That reach matters regardless of whether the specific transcript contains misinformation. The comment section and implied narrative ("and that's not even the end") suggest this is part of a weight loss progress series, a format that can range from genuinely helpful to medically problematic depending on what gets said across videos.

What should you actually know?

If you landed here looking for actual Wegovy information, here is what the evidence actually says:

• Semaglutide works by mimicking GLP-1, a hormone that slows gastric emptying and signals satiety to the brain. It is not a stimulant or appetite suppressant in the traditional sense.
• Weight loss results vary significantly. The 15% average from STEP 1 means roughly half of participants lost more and half lost less. Some people lose very little.
• Common side effects include nausea, vomiting, and constipation, particularly when doses are being increased. These are not signs the medication is not working.
• Wegovy is a brand-name drug with specific dosing approved by the FDA. Compounded semaglutide is not the same product. Do not assume equivalency.
• Long-term data beyond five years is still limited. This is a relatively new medication class at these doses.

Is there anything useful to take from this video?

Not medically, no. But the phenomenon of high-view GLP-1 content that is essentially unverifiable is itself worth paying attention to. When a video gets nearly 80,000 views under a drug-specific hashtag, people are forming impressions about that drug, whether or not anything substantive was said. The caption "and that's not even the end" signals an ongoing narrative that viewers are clearly invested in. That narrative, wherever it leads, carries real influence.